Home - Melanoma Research Alliance

Doing Good in Rebecca's Name

It was March of 2005 when Christine Garrison’s life changed forever. She received the phone call that no mother ever wants to receive. Her daughter Rebecca’s suspicious mole was, in fact, Stage 3 melanoma.
Read Christine's Story
Make Your Sun Safety Habit Stick: La Roche Posay’s My Skin Track UV

Many Americans are still getting too much sun despite knowing that nine out of every ten skin cancers, including melanoma, are caused by overexposure to ultraviolet radiation.

Last month’s arrival of La Roche Posay’s My Skin Track UV may be just what the doctor ordered.
Learn More
MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

MRA Scientific Advisory Panel Member & Grantee Dr. Jim Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.
Read More
When Astrophysics & Melanoma Collide

Dr. Janis taube, a dermatopathologist at Johns Hopkins University, is using lessons, processes, and tools from the field of astrophysics to approach melanoma in all new ways to better predict treatment outcomes.
Learn More
Improving the Lives of Melanoma Survivors

Melanoma survivors are at a 9-fold increased risk of developing another melanoma. Fortunately, in Dr. Rachel Vogel’s previous research, she found that most melanoma survivors adopt vigilant sun safe behaviors to mitigate this increased risk. Unfortunately, while most survivors adopt safer behaviors, 20% of survivors reported a sunburn in the past year and 10% intentionally went outside for a tan – both strong predictors of inappropriate sun exposure. She hopes to disrupt this cycle and to help melanoma survivors live better.
Read More
From Health Scare to Transformative Change

When Debra Black was diagnosed with Stage II acral melanoma, she was shocked to learn that the treatment landscape hadn’t changed in almost 40 years. So, later that year she and her husband Leon founded the Melanoma Research Alliance.

Since then, MRA has directly invested more than $101 million in cutting-edge melanoma research world-wide and has leveraged an additional $101 million from other sources.
Read Debra's Story

Find a Clinical Trial
Get Connected

Scientific Report
Get Involved
About MRA

What's New

12/18/2018 – MRA/ACS Joint Funding Opportunity: Understanding and Managing Metastasis

12/03/2018 – MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

11/01/2018 – Connecting the Dots: MRA’s 2017-2018 Annual Report

10/04/2018 – Melanoma Research Alliance Appoints Marc Hurlbert, Ph.D. Chief Science Officer

10/01/2018 – Melanoma Research Alliance Applauds Jim Allison for Nobel Prize in Medicine

MRA would like to thank our 2018 Retreat Sponsors